

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 9.95386464 |
| 2 | actin-mediated cell contraction (GO:0070252) | 9.75304720 |
| 3 | muscle cell fate commitment (GO:0042693) | 8.36104294 |
| 4 | skeletal muscle fiber development (GO:0048741) | 8.13971499 |
| 5 | * skeletal muscle adaptation (GO:0043501) | 7.83821842 |
| 6 | actin filament-based movement (GO:0030048) | 7.26017604 |
| 7 | glycogen catabolic process (GO:0005980) | 6.93859385 |
| 8 | myotube cell development (GO:0014904) | 6.93538478 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.89108321 |
| 10 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.68462188 |
| 11 | regulation of sarcomere organization (GO:0060297) | 6.51295777 |
| 12 | glucan catabolic process (GO:0009251) | 6.48862816 |
| 13 | striated muscle contraction (GO:0006941) | 6.27529848 |
| 14 | sarcomere organization (GO:0045214) | 6.26842843 |
| 15 | creatine metabolic process (GO:0006600) | 6.22443514 |
| 16 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 6.18499692 |
| 17 | carnitine shuttle (GO:0006853) | 6.14919659 |
| 18 | plasma membrane repair (GO:0001778) | 6.13979562 |
| 19 | cellular polysaccharide catabolic process (GO:0044247) | 5.99672609 |
| 20 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.98070041 |
| 21 | cardiac myofibril assembly (GO:0055003) | 5.87987998 |
| 22 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.86400303 |
| 23 | polysaccharide catabolic process (GO:0000272) | 5.80430181 |
| 24 | response to inactivity (GO:0014854) | 5.75278683 |
| 25 | membrane raft organization (GO:0031579) | 5.65965763 |
| 26 | regulation of cell communication by electrical coupling (GO:0010649) | 5.58530192 |
| 27 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.56261361 |
| 28 | purine nucleotide salvage (GO:0032261) | 5.53189703 |
| 29 | myofibril assembly (GO:0030239) | 5.34729904 |
| 30 | negative regulation of protein localization to cell surface (GO:2000009) | 5.34715457 |
| 31 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.33754181 |
| 32 | muscle contraction (GO:0006936) | 5.25694971 |
| 33 | membrane assembly (GO:0071709) | 5.16919460 |
| 34 | fatty acid transmembrane transport (GO:1902001) | 5.13858580 |
| 35 | cytidine deamination (GO:0009972) | 5.11260801 |
| 36 | cytidine metabolic process (GO:0046087) | 5.11260801 |
| 37 | cytidine catabolic process (GO:0006216) | 5.11260801 |
| 38 | glycogen biosynthetic process (GO:0005978) | 5.04592423 |
| 39 | glucan biosynthetic process (GO:0009250) | 5.04592423 |
| 40 | muscle fiber development (GO:0048747) | 4.89191793 |
| 41 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.82927140 |
| 42 | glycogen metabolic process (GO:0005977) | 4.64972499 |
| 43 | * muscle system process (GO:0003012) | 4.59182145 |
| 44 | cellular glucan metabolic process (GO:0006073) | 4.55400092 |
| 45 | glucan metabolic process (GO:0044042) | 4.55400092 |
| 46 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.55131263 |
| 47 | IMP metabolic process (GO:0046040) | 4.50200729 |
| 48 | carnitine transmembrane transport (GO:1902603) | 4.45794817 |
| 49 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.45622402 |
| 50 | musculoskeletal movement (GO:0050881) | 4.41879734 |
| 51 | multicellular organismal movement (GO:0050879) | 4.41879734 |
| 52 | syncytium formation by plasma membrane fusion (GO:0000768) | 4.34772553 |
| 53 | neuronal action potential propagation (GO:0019227) | 4.32816135 |
| 54 | actomyosin structure organization (GO:0031032) | 4.29518636 |
| 55 | striated muscle tissue development (GO:0014706) | 4.23598963 |
| 56 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.19149059 |
| 57 | negative regulation of organelle assembly (GO:1902116) | 4.17958383 |
| 58 | * striated muscle adaptation (GO:0014888) | 4.15071857 |
| 59 | * skeletal muscle tissue regeneration (GO:0043403) | 4.11672891 |
| 60 | neuromuscular synaptic transmission (GO:0007274) | 4.10589516 |
| 61 | amino-acid betaine transport (GO:0015838) | 4.05039725 |
| 62 | carnitine transport (GO:0015879) | 4.05039725 |
| 63 | * response to muscle activity (GO:0014850) | 3.99213835 |
| 64 | muscle cell cellular homeostasis (GO:0046716) | 3.90405375 |
| 65 | muscle tissue development (GO:0060537) | 3.81835360 |
| 66 | regulation of cofactor metabolic process (GO:0051193) | 3.80703798 |
| 67 | regulation of coenzyme metabolic process (GO:0051196) | 3.80703798 |
| 68 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.76204153 |
| 69 | cellular carbohydrate catabolic process (GO:0044275) | 3.74685172 |
| 70 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.71776818 |
| 71 | myotube differentiation (GO:0014902) | 3.71377979 |
| 72 | negative regulation of monooxygenase activity (GO:0032769) | 3.69048659 |
| 73 | muscle tissue morphogenesis (GO:0060415) | 3.65290701 |
| 74 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.64033504 |
| 75 | regulation of cardiac muscle cell differentiation (GO:2000725) | 3.59693515 |
| 76 | * negative regulation of muscle hypertrophy (GO:0014741) | 3.59637108 |
| 77 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.59637108 |
| 78 | syncytium formation (GO:0006949) | 3.58746318 |
| 79 | cardiac muscle contraction (GO:0060048) | 3.53845573 |
| 80 | striated muscle cell development (GO:0055002) | 3.50049659 |
| 81 | * muscle organ development (GO:0007517) | 3.49203141 |
| 82 | regulation of membrane repolarization (GO:0060306) | 3.47618985 |
| 83 | positive regulation of skeletal muscle tissue development (GO:0048643) | 3.47063975 |
| 84 | regulation of relaxation of muscle (GO:1901077) | 3.44689341 |
| 85 | * muscle structure development (GO:0061061) | 3.43755000 |
| 86 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.42651361 |
| 87 | * striated muscle atrophy (GO:0014891) | 3.40019380 |
| 88 | negative regulation of heart growth (GO:0061117) | 3.39028125 |
| 89 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.39028125 |
| 90 | IMP biosynthetic process (GO:0006188) | 3.36793891 |
| 91 | * muscle adaptation (GO:0043500) | 3.36357112 |
| 92 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.35652365 |
| 93 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.35652365 |
| 94 | regulation of sequestering of calcium ion (GO:0051282) | 3.34944078 |
| 95 | skeletal muscle tissue development (GO:0007519) | 3.31334043 |
| 96 | negative regulation of cell size (GO:0045792) | 3.30495924 |
| 97 | generation of neurons (GO:0048699) | 3.30321952 |
| 98 | positive regulation of striated muscle cell differentiation (GO:0051155) | 3.30186017 |
| 99 | positive regulation of myoblast differentiation (GO:0045663) | 3.28724803 |
| 100 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.27997256 |
| 101 | metanephric mesenchyme development (GO:0072075) | 3.27011659 |
| 102 | organ induction (GO:0001759) | 3.25653954 |
| 103 | * response to activity (GO:0014823) | 3.25025038 |
| 104 | tricarboxylic acid cycle (GO:0006099) | 3.24990332 |
| 105 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.23099001 |
| 106 | cellular polysaccharide metabolic process (GO:0044264) | 3.21176720 |
| 107 | regulation of muscle adaptation (GO:0043502) | 3.19418150 |
| 108 | positive regulation of muscle cell differentiation (GO:0051149) | 3.16746298 |
| 109 | neuromuscular junction development (GO:0007528) | 3.14382261 |
| 110 | regulation of striated muscle contraction (GO:0006942) | 3.11635819 |
| 111 | myoblast fusion (GO:0007520) | 3.11517980 |
| 112 | heart process (GO:0003015) | 3.10494126 |
| 113 | heart contraction (GO:0060047) | 3.10494126 |
| 114 | synaptic transmission, cholinergic (GO:0007271) | 3.08944375 |
| 115 | positive regulation of myotube differentiation (GO:0010831) | 3.07489560 |
| 116 | regulation of sulfur metabolic process (GO:0042762) | 3.05146541 |
| 117 | regulation of alkaline phosphatase activity (GO:0010692) | 3.04730168 |
| 118 | endoplasmic reticulum organization (GO:0007029) | 3.03712864 |
| 119 | cardiac muscle cell development (GO:0055013) | 3.02610829 |
| 120 | polysaccharide metabolic process (GO:0005976) | 3.01385061 |
| 121 | intracellular lipid transport (GO:0032365) | 3.01062152 |
| 122 | calcium ion transport into cytosol (GO:0060402) | 2.99850203 |
| 123 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.98532187 |
| 124 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.98299790 |
| 125 | muscle cell development (GO:0055001) | 2.97841314 |
| 126 | regulation of actin filament-based movement (GO:1903115) | 2.97602109 |
| 127 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96385525 |
| 128 | * muscle atrophy (GO:0014889) | 2.96264639 |
| 129 | regulation of p38MAPK cascade (GO:1900744) | 2.95728502 |
| 130 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.92663027 |
| 131 | actin filament depolymerization (GO:0030042) | 2.92508216 |
| 132 | cellular polysaccharide biosynthetic process (GO:0033692) | 2.92379436 |
| 133 | cytosolic calcium ion transport (GO:0060401) | 2.92038494 |
| 134 | regulation of myoblast differentiation (GO:0045661) | 2.91333522 |
| 135 | positive regulation of microtubule polymerization (GO:0031116) | 2.91248916 |
| 136 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.90770754 |
| 137 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.89901672 |
| 138 | polysaccharide biosynthetic process (GO:0000271) | 2.89439269 |
| 139 | regulation of metalloenzyme activity (GO:0048552) | 2.89169812 |
| 140 | regulation of action potential (GO:0098900) | 2.88068976 |
| 141 | fatty acid homeostasis (GO:0055089) | 2.87835551 |
| 142 | kidney mesenchyme development (GO:0072074) | 2.87418902 |
| 143 | * regulation of muscle system process (GO:0090257) | 2.87048556 |
| 144 | anterior/posterior axis specification, embryo (GO:0008595) | 2.86702216 |
| 145 | cardiac cell development (GO:0055006) | 2.84463260 |
| 146 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.81315256 |
| 147 | actin-myosin filament sliding (GO:0033275) | 11.9507339 |
| 148 | muscle filament sliding (GO:0030049) | 11.9507339 |
| 149 | regulation of skeletal muscle contraction (GO:0014819) | 11.7884614 |
| 150 | skeletal muscle contraction (GO:0003009) | 10.5649989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.38943217 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.88377053 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.79377619 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.66736998 |
| 5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.10452494 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.95091909 |
| 7 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.77283696 |
| 8 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.66370600 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.58674015 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.44034236 |
| 11 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.41006782 |
| 12 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.39954252 |
| 13 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.39731398 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.34751435 |
| 15 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.30758199 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.30248226 |
| 17 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.27410598 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.21217470 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.13827891 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 2.11906423 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.08018278 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.05249540 |
| 23 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.02688181 |
| 24 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.02301124 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.91759186 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.87140607 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.85466378 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.82017763 |
| 29 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.79542323 |
| 30 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.79542323 |
| 31 | CJUN_26792858_Chip-Seq_BT549_Human | 1.79377055 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79314900 |
| 33 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.76998102 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.74814721 |
| 35 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.74587307 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.72604434 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.69736546 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.68975457 |
| 39 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.67341774 |
| 40 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.60089386 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.58193760 |
| 42 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.57651854 |
| 43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.57212662 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.56007725 |
| 45 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.54992300 |
| 46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.54845275 |
| 47 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.54751789 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.53555556 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52817460 |
| 50 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.52237156 |
| 51 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.52237156 |
| 52 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.51576012 |
| 53 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.50470345 |
| 54 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.50031690 |
| 55 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.49805711 |
| 56 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.48890896 |
| 57 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.48598161 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.48377256 |
| 59 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.45883377 |
| 60 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.45219393 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43860407 |
| 62 | KDM2B_26808549_Chip-Seq_REH_Human | 1.43381473 |
| 63 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.43037470 |
| 64 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.39120397 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.38319979 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.35091434 |
| 67 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.34373766 |
| 68 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.30975798 |
| 69 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.30124088 |
| 70 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.29955180 |
| 71 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.29936005 |
| 72 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28623938 |
| 73 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.28551464 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28391516 |
| 75 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.28111577 |
| 76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27216082 |
| 77 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25076668 |
| 78 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.24385668 |
| 79 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23050513 |
| 80 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22509874 |
| 81 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.22288390 |
| 82 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22283745 |
| 83 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.22184197 |
| 84 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.20151226 |
| 85 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.20151226 |
| 86 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.20151226 |
| 87 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19958675 |
| 88 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16914741 |
| 89 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.15528478 |
| 90 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15236238 |
| 91 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.15013598 |
| 92 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14723272 |
| 93 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14408429 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14396596 |
| 95 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.14118432 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14038875 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14007749 |
| 98 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.13096199 |
| 99 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12709069 |
| 100 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.12590405 |
| 101 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11789324 |
| 102 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11457164 |
| 103 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11010360 |
| 104 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.10610197 |
| 105 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09661192 |
| 106 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09273594 |
| 107 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.08774868 |
| 108 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.08774868 |
| 109 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08262707 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07590573 |
| 111 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05424507 |
| 112 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05223508 |
| 113 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05171524 |
| 114 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.04752231 |
| 115 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04531325 |
| 116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01739834 |
| 117 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.01386283 |
| 118 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.01278455 |
| 119 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.00717195 |
| 120 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00670986 |
| 121 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00333379 |
| 122 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00120918 |
| 123 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99251516 |
| 124 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98478170 |
| 125 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97647093 |
| 126 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.97609894 |
| 127 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97126787 |
| 128 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95414658 |
| 129 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95384012 |
| 130 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94713432 |
| 131 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.94009549 |
| 132 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.93835285 |
| 133 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93460694 |
| 134 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.92285150 |
| 135 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.91890921 |
| 136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90375135 |
| 137 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90375135 |
| 138 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.90203394 |
| 139 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.89339103 |
| 140 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88322464 |
| 141 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88252080 |
| 142 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.87299861 |
| 143 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.87147652 |
| 144 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86671116 |
| 145 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.86649733 |
| 146 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.86336395 |
| 147 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85731819 |
| 148 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.85694697 |
| 149 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.85222505 |
| 150 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85193164 |
| 151 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83792243 |
| 152 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83322403 |
| 153 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83195154 |
| 154 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82431240 |
| 155 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81389457 |
| 156 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.81288908 |
| 157 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80968483 |
| 158 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.80070553 |
| 159 | KDM2B_26808549_Chip-Seq_K562_Human | 0.79840666 |
| 160 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.79339651 |
| 161 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79225803 |
| 162 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.78749512 |
| 163 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.78573711 |
| 164 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.78486901 |
| 165 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78402767 |
| 166 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.78311743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.04233540 |
| 2 | MP0000749_muscle_degeneration | 6.22258930 |
| 3 | MP0003646_muscle_fatigue | 6.08832058 |
| 4 | MP0000751_myopathy | 5.58035686 |
| 5 | MP0000747_muscle_weakness | 4.46250363 |
| 6 | * MP0002106_abnormal_muscle_physiology | 4.13695904 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.13470429 |
| 8 | * MP0000759_abnormal_skeletal_muscle | 3.72500769 |
| 9 | MP0002269_muscular_atrophy | 3.59644164 |
| 10 | MP0004130_abnormal_muscle_cell | 3.52403656 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 3.52163510 |
| 12 | * MP0005369_muscle_phenotype | 3.44676874 |
| 13 | * MP0004087_abnormal_muscle_fiber | 3.19445960 |
| 14 | MP0005620_abnormal_muscle_contractility | 3.16513424 |
| 15 | MP0000750_abnormal_muscle_regeneration | 2.99699047 |
| 16 | MP0008438_abnormal_cutaneous_collagen | 2.91269945 |
| 17 | MP0004233_abnormal_muscle_weight | 2.73153858 |
| 18 | MP0000733_abnormal_muscle_development | 2.22549023 |
| 19 | MP0002332_abnormal_exercise_endurance | 2.18580718 |
| 20 | MP0004270_analgesia | 2.08641076 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 1.83426418 |
| 22 | * MP0002108_abnormal_muscle_morphology | 1.72091442 |
| 23 | MP0001542_abnormal_bone_strength | 1.71467118 |
| 24 | MP0005330_cardiomyopathy | 1.70414226 |
| 25 | MP0003828_pulmonary_edema | 1.67747324 |
| 26 | MP0004185_abnormal_adipocyte_glucose | 1.63315515 |
| 27 | MP0005275_abnormal_skin_tensile | 1.59819925 |
| 28 | MP0002971_abnormal_brown_adipose | 1.57802959 |
| 29 | MP0003279_aneurysm | 1.54192977 |
| 30 | MP0010030_abnormal_orbit_morphology | 1.50551936 |
| 31 | MP0004084_abnormal_cardiac_muscle | 1.44526012 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.27374780 |
| 33 | MP0004215_abnormal_myocardial_fiber | 1.25602880 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.21227351 |
| 35 | MP0000013_abnormal_adipose_tissue | 1.20362184 |
| 36 | MP0004272_abnormal_basement_membrane | 1.16559030 |
| 37 | MP0004484_altered_response_of | 1.11755190 |
| 38 | MP0005266_abnormal_metabolism | 1.07277677 |
| 39 | MP0005375_adipose_tissue_phenotype | 1.04275751 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.03933659 |
| 41 | MP0005171_absent_coat_pigmentation | 1.01508305 |
| 42 | MP0000467_abnormal_esophagus_morphology | 1.00255357 |
| 43 | MP0005360_urolithiasis | 0.99330180 |
| 44 | MP0001958_emphysema | 0.98988202 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 0.98504580 |
| 46 | MP0010630_abnormal_cardiac_muscle | 0.95896940 |
| 47 | MP0002796_impaired_skin_barrier | 0.95734332 |
| 48 | MP0001485_abnormal_pinna_reflex | 0.92363087 |
| 49 | MP0005623_abnormal_meninges_morphology | 0.91982748 |
| 50 | MP0000767_abnormal_smooth_muscle | 0.91743656 |
| 51 | MP0001299_abnormal_eye_distance/ | 0.90006275 |
| 52 | MP0004883_abnormal_blood_vessel | 0.89929024 |
| 53 | MP0002102_abnormal_ear_morphology | 0.89908263 |
| 54 | MP0008789_abnormal_olfactory_epithelium | 0.88426731 |
| 55 | MP0000569_abnormal_digit_pigmentation | 0.87371545 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 0.87065536 |
| 57 | MP0000372_irregular_coat_pigmentation | 0.86575538 |
| 58 | MP0006035_abnormal_mitochondrial_morpho | 0.84633792 |
| 59 | MP0001544_abnormal_cardiovascular_syste | 0.81996867 |
| 60 | MP0005385_cardiovascular_system_phenoty | 0.81996867 |
| 61 | MP0003137_abnormal_impulse_conducting | 0.80410837 |
| 62 | MP0009384_cardiac_valve_regurgitation | 0.78310790 |
| 63 | MP0004134_abnormal_chest_morphology | 0.76939108 |
| 64 | MP0000003_abnormal_adipose_tissue | 0.75292284 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 0.72354371 |
| 66 | MP0003385_abnormal_body_wall | 0.71334833 |
| 67 | * MP0002078_abnormal_glucose_homeostasis | 0.70818338 |
| 68 | MP0002254_reproductive_system_inflammat | 0.69718191 |
| 69 | MP0005595_abnormal_vascular_smooth | 0.69042524 |
| 70 | MP0001661_extended_life_span | 0.68062990 |
| 71 | MP0008961_abnormal_basal_metabolism | 0.67458257 |
| 72 | MP0002234_abnormal_pharynx_morphology | 0.67182624 |
| 73 | MP0003091_abnormal_cell_migration | 0.66501572 |
| 74 | MP0009250_abnormal_appendicular_skeleto | 0.63524247 |
| 75 | MP0002734_abnormal_mechanical_nocicepti | 0.63159024 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.63132773 |
| 77 | MP0000762_abnormal_tongue_morphology | 0.62364958 |
| 78 | * MP0005334_abnormal_fat_pad | 0.59531419 |
| 79 | MP0002933_joint_inflammation | 0.59387481 |
| 80 | MP0000534_abnormal_ureter_morphology | 0.57793791 |
| 81 | MP0002168_other_aberrant_phenotype | 0.57572483 |
| 82 | MP0004147_increased_porphyrin_level | 0.57224002 |
| 83 | MP0000579_abnormal_nail_morphology | 0.54719227 |
| 84 | MP0008569_lethality_at_weaning | 0.54296119 |
| 85 | MP0002184_abnormal_innervation | 0.54238290 |
| 86 | MP0005023_abnormal_wound_healing | 0.53696988 |
| 87 | * MP0005452_abnormal_adipose_tissue | 0.53279169 |
| 88 | MP0003755_abnormal_palate_morphology | 0.53165190 |
| 89 | MP0003045_fibrosis | 0.52200355 |
| 90 | MP0004859_abnormal_synaptic_plasticity | 0.51952615 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.51280962 |
| 92 | MP0004043_abnormal_pH_regulation | 0.51259943 |
| 93 | MP0004510_myositis | 0.51210372 |
| 94 | MP0000383_abnormal_hair_follicle | 0.50481852 |
| 95 | MP0010368_abnormal_lymphatic_system | 0.49199970 |
| 96 | MP0001486_abnormal_startle_reflex | 0.49156390 |
| 97 | MP0005388_respiratory_system_phenotype | 0.48597159 |
| 98 | MP0002133_abnormal_respiratory_system | 0.48597159 |
| 99 | MP0003935_abnormal_craniofacial_develop | 0.47889600 |
| 100 | MP0004142_abnormal_muscle_tone | 0.47580092 |
| 101 | MP0002233_abnormal_nose_morphology | 0.47550227 |
| 102 | MP0005503_abnormal_tendon_morphology | 0.47205319 |
| 103 | MP0001346_abnormal_lacrimal_gland | 0.47067900 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.46335013 |
| 105 | MP0003195_calcinosis | 0.46167165 |
| 106 | MP0000685_abnormal_immune_system | 0.44727007 |
| 107 | MP0005670_abnormal_white_adipose | 0.44147939 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.43416601 |
| 109 | MP0002113_abnormal_skeleton_development | 0.41160512 |
| 110 | MP0000163_abnormal_cartilage_morphology | 0.40848528 |
| 111 | MP0003948_abnormal_gas_homeostasis | 0.38759359 |
| 112 | MP0005535_abnormal_body_temperature | 0.38701899 |
| 113 | * MP0000266_abnormal_heart_morphology | 0.37765617 |
| 114 | MP0003950_abnormal_plasma_membrane | 0.37691208 |
| 115 | MP0002128_abnormal_blood_circulation | 0.36874994 |
| 116 | MP0008775_abnormal_heart_ventricle | 0.36494845 |
| 117 | MP0003136_yellow_coat_color | 0.36207625 |
| 118 | MP0002932_abnormal_joint_morphology | 0.35863747 |
| 119 | MP0002138_abnormal_hepatobiliary_system | 0.35804758 |
| 120 | MP0006138_congestive_heart_failure | 0.35625573 |
| 121 | MP0000343_altered_response_to | 0.35225518 |
| 122 | MP0001849_ear_inflammation | 0.34730611 |
| 123 | MP0009115_abnormal_fat_cell | 0.34578282 |
| 124 | MP0005501_abnormal_skin_physiology | 0.34334253 |
| 125 | MP0010678_abnormal_skin_adnexa | 0.33593514 |
| 126 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.33158617 |
| 127 | MP0002066_abnormal_motor_capabilities/c | 0.32950364 |
| 128 | MP0005448_abnormal_energy_balance | 0.32915441 |
| 129 | MP0001502_abnormal_circadian_rhythm | 0.32247839 |
| 130 | MP0009672_abnormal_birth_weight | 0.31906928 |
| 131 | MP0001943_abnormal_respiration | 0.31196324 |
| 132 | MP0001348_abnormal_lacrimal_gland | 0.30158520 |
| 133 | MP0002127_abnormal_cardiovascular_syste | 0.29545124 |
| 134 | * MP0002896_abnormal_bone_mineralization | 0.28878808 |
| 135 | MP0002909_abnormal_adrenal_gland | 0.28184134 |
| 136 | MP0001243_abnormal_dermal_layer | 0.28121892 |
| 137 | MP0009780_abnormal_chondrocyte_physiolo | 0.27934956 |
| 138 | MP0005376_homeostasis/metabolism_phenot | 0.27846658 |
| 139 | MP0002114_abnormal_axial_skeleton | 0.27648332 |
| 140 | MP0005647_abnormal_sex_gland | 0.27543152 |
| 141 | MP0005645_abnormal_hypothalamus_physiol | 0.27192777 |
| 142 | MP0002970_abnormal_white_adipose | 0.27018742 |
| 143 | MP0002876_abnormal_thyroid_physiology | 0.26370939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.52310188 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.24613753 |
| 3 | Popliteal pterygium (HP:0009756) | 8.71214456 |
| 4 | Exercise-induced myalgia (HP:0003738) | 8.70334413 |
| 5 | Nemaline bodies (HP:0003798) | 8.54278326 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 7.99052870 |
| 7 | Distal arthrogryposis (HP:0005684) | 7.54933449 |
| 8 | Type 2 muscle fiber atrophy (HP:0003554) | 7.29531488 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 6.81424911 |
| 10 | Myopathic facies (HP:0002058) | 6.76326127 |
| 11 | Abnormality of placental membranes (HP:0011409) | 6.65225280 |
| 12 | Amniotic constriction ring (HP:0009775) | 6.65225280 |
| 13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.59398365 |
| 14 | Muscle fiber atrophy (HP:0100295) | 6.49622421 |
| 15 | Round ear (HP:0100830) | 6.35359042 |
| 16 | Ulnar deviation of the wrist (HP:0003049) | 6.25628075 |
| 17 | Calf muscle hypertrophy (HP:0008981) | 5.79553871 |
| 18 | Difficulty running (HP:0009046) | 5.45169741 |
| 19 | Calcaneovalgus deformity (HP:0001848) | 5.44787376 |
| 20 | Myoglobinuria (HP:0002913) | 5.28290177 |
| 21 | Absent phalangeal crease (HP:0006109) | 5.18241610 |
| 22 | Muscle fiber splitting (HP:0003555) | 5.16558895 |
| 23 | Deformed tarsal bones (HP:0008119) | 4.90844309 |
| 24 | Muscle stiffness (HP:0003552) | 4.78225114 |
| 25 | Hyporeflexia of lower limbs (HP:0002600) | 4.59339182 |
| 26 | EMG: myopathic abnormalities (HP:0003458) | 4.45922869 |
| 27 | Rhabdomyolysis (HP:0003201) | 4.37030409 |
| 28 | Increased connective tissue (HP:0009025) | 4.34386830 |
| 29 | Abnormal finger flexion creases (HP:0006143) | 4.32428601 |
| 30 | Aplasia of the musculature (HP:0100854) | 4.29056389 |
| 31 | Myotonia (HP:0002486) | 4.11429989 |
| 32 | Easy fatigability (HP:0003388) | 4.04149890 |
| 33 | Pterygium (HP:0001059) | 3.99312855 |
| 34 | Abnormality of the calf musculature (HP:0001430) | 3.88051566 |
| 35 | Thin ribs (HP:0000883) | 3.80719238 |
| 36 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.63835500 |
| 37 | Rimmed vacuoles (HP:0003805) | 3.62260592 |
| 38 | Malignant hyperthermia (HP:0002047) | 3.61527562 |
| 39 | Shoulder girdle muscle weakness (HP:0003547) | 3.58309149 |
| 40 | Akinesia (HP:0002304) | 3.52677437 |
| 41 | Pelvic girdle muscle weakness (HP:0003749) | 3.47772271 |
| 42 | Neck muscle weakness (HP:0000467) | 3.39634924 |
| 43 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.37132994 |
| 44 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.37132994 |
| 45 | Difficulty climbing stairs (HP:0003551) | 3.33714786 |
| 46 | Increased variability in muscle fiber diameter (HP:0003557) | 3.32539019 |
| 47 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.31685005 |
| 48 | Subaortic stenosis (HP:0001682) | 3.31685005 |
| 49 | Abnormality of the calcaneus (HP:0008364) | 3.23006538 |
| 50 | Frequent falls (HP:0002359) | 3.06658551 |
| 51 | Areflexia of lower limbs (HP:0002522) | 3.00279517 |
| 52 | Depressed nasal tip (HP:0000437) | 2.93074826 |
| 53 | Hyperkalemia (HP:0002153) | 2.92962855 |
| 54 | Cystic hygroma (HP:0000476) | 2.92850597 |
| 55 | Palpebral edema (HP:0100540) | 2.90484606 |
| 56 | Abnormality of the neuromuscular junction (HP:0003398) | 2.76626110 |
| 57 | Fatigable weakness (HP:0003473) | 2.76626110 |
| 58 | Decreased muscle mass (HP:0003199) | 2.63523242 |
| 59 | Paralysis (HP:0003470) | 2.59488003 |
| 60 | Sudden death (HP:0001699) | 2.59107130 |
| 61 | Asymmetric septal hypertrophy (HP:0001670) | 2.53747711 |
| 62 | Slender build (HP:0001533) | 2.48775766 |
| 63 | Mask-like facies (HP:0000298) | 2.46340779 |
| 64 | EMG: neuropathic changes (HP:0003445) | 2.40958600 |
| 65 | Aortic aneurysm (HP:0004942) | 2.36823831 |
| 66 | Muscular dystrophy (HP:0003560) | 2.33971937 |
| 67 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.31117591 |
| 68 | Limb-girdle muscle weakness (HP:0003325) | 2.28837308 |
| 69 | Aortic dissection (HP:0002647) | 2.25867244 |
| 70 | Distal lower limb muscle weakness (HP:0009053) | 2.23602238 |
| 71 | Hypoplastic ischia (HP:0003175) | 2.22546404 |
| 72 | Arterial tortuosity (HP:0005116) | 2.18915166 |
| 73 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.17012939 |
| 74 | Metatarsus adductus (HP:0001840) | 2.15736679 |
| 75 | Ulnar deviation of finger (HP:0009465) | 2.15257311 |
| 76 | Bulbar palsy (HP:0001283) | 2.14929929 |
| 77 | Generalized muscle weakness (HP:0003324) | 2.14006166 |
| 78 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.12961237 |
| 79 | Webbed neck (HP:0000465) | 2.08901514 |
| 80 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.03720997 |
| 81 | Bell-shaped thorax (HP:0001591) | 2.03532127 |
| 82 | Hip contracture (HP:0003273) | 2.03473496 |
| 83 | Hypoplastic heart (HP:0001961) | 2.02859586 |
| 84 | Proximal amyotrophy (HP:0007126) | 2.02822524 |
| 85 | Nonprogressive disorder (HP:0003680) | 2.02440136 |
| 86 | Vascular tortuosity (HP:0004948) | 2.00954938 |
| 87 | Poor suck (HP:0002033) | 1.99044999 |
| 88 | Lipoatrophy (HP:0100578) | 1.97327078 |
| 89 | Spinal rigidity (HP:0003306) | 1.96339793 |
| 90 | Abnormality of the ischium (HP:0003174) | 1.95650329 |
| 91 | Scapular winging (HP:0003691) | 1.94319381 |
| 92 | Achilles tendon contracture (HP:0001771) | 1.93072562 |
| 93 | Facial diplegia (HP:0001349) | 1.92901240 |
| 94 | Limb-girdle muscle atrophy (HP:0003797) | 1.92807993 |
| 95 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.92172367 |
| 96 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.90961054 |
| 97 | Oligomenorrhea (HP:0000876) | 1.86441498 |
| 98 | Distal lower limb amyotrophy (HP:0008944) | 1.84338663 |
| 99 | Gowers sign (HP:0003391) | 1.83450596 |
| 100 | Stridor (HP:0010307) | 1.82324417 |
| 101 | Fetal akinesia sequence (HP:0001989) | 1.79959182 |
| 102 | Ventricular tachycardia (HP:0004756) | 1.79245325 |
| 103 | Arthrogryposis multiplex congenita (HP:0002804) | 1.79105912 |
| 104 | Hyperglycemia (HP:0003074) | 1.78889461 |
| 105 | Trismus (HP:0000211) | 1.77992366 |
| 106 | Diminished movement (HP:0002374) | 1.77192579 |
| 107 | Weak cry (HP:0001612) | 1.76692749 |
| 108 | Abnormality of the Achilles tendon (HP:0005109) | 1.75430325 |
| 109 | Microglossia (HP:0000171) | 1.74149187 |
| 110 | Fibular aplasia (HP:0002990) | 1.71591319 |
| 111 | Protrusio acetabuli (HP:0003179) | 1.71018598 |
| 112 | Cholelithiasis (HP:0001081) | 1.70108535 |
| 113 | Limited hip movement (HP:0008800) | 1.70033114 |
| 114 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.69078749 |
| 115 | Hyperuricemia (HP:0002149) | 1.68346229 |
| 116 | Increased purine levels (HP:0004368) | 1.68346229 |
| 117 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.67788186 |
| 118 | Tarsal synostosis (HP:0008368) | 1.65790182 |
| 119 | Waddling gait (HP:0002515) | 1.65092183 |
| 120 | Progressive muscle weakness (HP:0003323) | 1.65027821 |
| 121 | Rocker bottom foot (HP:0001838) | 1.62116405 |
| 122 | Gout (HP:0001997) | 1.59787146 |
| 123 | Abnormality of potassium homeostasis (HP:0011042) | 1.59228020 |
| 124 | Adducted thumb (HP:0001181) | 1.58897130 |
| 125 | Delayed gross motor development (HP:0002194) | 1.57675443 |
| 126 | Short palpebral fissure (HP:0012745) | 1.57492407 |
| 127 | Abnormal gallbladder morphology (HP:0012437) | 1.56310472 |
| 128 | Increased density of long bones (HP:0006392) | 1.50831550 |
| 129 | Synostosis involving bones of the feet (HP:0009140) | 1.50405972 |
| 130 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.50405972 |
| 131 | Abnormality of the umbilical cord (HP:0010881) | 1.46113287 |
| 132 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.46041522 |
| 133 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.44222627 |
| 134 | Long clavicles (HP:0000890) | 1.43596208 |
| 135 | Spondylolisthesis (HP:0003302) | 1.43510726 |
| 136 | Left ventricular hypertrophy (HP:0001712) | 1.43431538 |
| 137 | Prolonged QT interval (HP:0001657) | 1.43400328 |
| 138 | Hypokalemia (HP:0002900) | 1.42326166 |
| 139 | Wrist flexion contracture (HP:0001239) | 1.39713362 |
| 140 | Lower limb amyotrophy (HP:0007210) | 1.39227402 |
| 141 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.38020249 |
| 142 | Exercise intolerance (HP:0003546) | 1.37671382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.44672558 |
| 2 | PHKG1 | 6.00102509 |
| 3 | PHKG2 | 6.00102509 |
| 4 | TTN | 5.90681429 |
| 5 | NME1 | 4.63907634 |
| 6 | PIK3CG | 3.66101281 |
| 7 | MAP3K12 | 3.30385571 |
| 8 | BRD4 | 2.72151301 |
| 9 | NEK1 | 2.53146230 |
| 10 | CCNB1 | 2.40688135 |
| 11 | MAP2K3 | 2.35541957 |
| 12 | PINK1 | 2.30288234 |
| 13 | MAP3K7 | 2.08108165 |
| 14 | PDK4 | 1.80492362 |
| 15 | PDK3 | 1.80492362 |
| 16 | MAPKAPK5 | 1.72849472 |
| 17 | MAP2K4 | 1.72338228 |
| 18 | PIK3CA | 1.67589201 |
| 19 | ERBB3 | 1.60576477 |
| 20 | MAPK12 | 1.55166270 |
| 21 | MYLK | 1.52087718 |
| 22 | TRIB3 | 1.46532698 |
| 23 | MAP2K6 | 1.45965867 |
| 24 | BCKDK | 1.40254435 |
| 25 | DMPK | 1.36867498 |
| 26 | EIF2AK3 | 1.33756826 |
| 27 | CDK8 | 1.27486483 |
| 28 | NEK9 | 1.26703135 |
| 29 | TIE1 | 1.12144594 |
| 30 | MAPK15 | 1.11078865 |
| 31 | DYRK1B | 1.10811754 |
| 32 | MUSK | 1.08255015 |
| 33 | PDK2 | 1.06194593 |
| 34 | TGFBR2 | 1.06093348 |
| 35 | MELK | 1.02000000 |
| 36 | DYRK3 | 0.93327968 |
| 37 | FGFR1 | 0.91202210 |
| 38 | PRKAA2 | 0.90220828 |
| 39 | STK24 | 0.89546144 |
| 40 | PRKAA1 | 0.84800447 |
| 41 | TAOK1 | 0.83059671 |
| 42 | MAPKAPK3 | 0.81851384 |
| 43 | EIF2AK2 | 0.79367358 |
| 44 | LIMK1 | 0.77173437 |
| 45 | KSR2 | 0.71780927 |
| 46 | MAP3K3 | 0.71776332 |
| 47 | PLK2 | 0.70621916 |
| 48 | EIF2AK1 | 0.69282357 |
| 49 | DAPK3 | 0.64642403 |
| 50 | TAF1 | 0.64535925 |
| 51 | CAMK2B | 0.63469279 |
| 52 | CDK4 | 0.60769896 |
| 53 | NTRK2 | 0.59590310 |
| 54 | EPHB1 | 0.59235166 |
| 55 | CAMK2G | 0.59108966 |
| 56 | PDGFRA | 0.57244939 |
| 57 | ROCK2 | 0.56710439 |
| 58 | PAK4 | 0.56617350 |
| 59 | FGFR2 | 0.55530930 |
| 60 | PRKD3 | 0.53635336 |
| 61 | PAK6 | 0.52651780 |
| 62 | MAP3K6 | 0.52586701 |
| 63 | PAK2 | 0.51414788 |
| 64 | MAPK11 | 0.50774479 |
| 65 | TYRO3 | 0.50199841 |
| 66 | TAOK2 | 0.50105427 |
| 67 | CDK9 | 0.49927173 |
| 68 | LATS2 | 0.48625399 |
| 69 | ILK | 0.47741146 |
| 70 | SGK2 | 0.47210301 |
| 71 | SIK1 | 0.46337476 |
| 72 | KSR1 | 0.45920038 |
| 73 | NUAK1 | 0.44450712 |
| 74 | CHEK2 | 0.44210670 |
| 75 | TRPM7 | 0.44148959 |
| 76 | DAPK2 | 0.44082798 |
| 77 | VRK2 | 0.43852609 |
| 78 | LATS1 | 0.43660157 |
| 79 | PTK6 | 0.42586284 |
| 80 | WNK1 | 0.41891764 |
| 81 | PKN2 | 0.41180818 |
| 82 | MARK2 | 0.40405727 |
| 83 | RPS6KB1 | 0.38894606 |
| 84 | STK39 | 0.38876387 |
| 85 | AKT2 | 0.38682119 |
| 86 | ERBB4 | 0.37458707 |
| 87 | MARK1 | 0.36390853 |
| 88 | MAP3K10 | 0.36124250 |
| 89 | SGK1 | 0.35537761 |
| 90 | ABL1 | 0.35428256 |
| 91 | RIPK1 | 0.34968863 |
| 92 | MAP3K9 | 0.32794860 |
| 93 | ZAK | 0.32635101 |
| 94 | PTK2 | 0.32473066 |
| 95 | CAMK2A | 0.31027009 |
| 96 | MAP3K4 | 0.29853771 |
| 97 | DAPK1 | 0.29545213 |
| 98 | CASK | 0.29314789 |
| 99 | PKN1 | 0.29272548 |
| 100 | CSNK1G1 | 0.28230767 |
| 101 | CSNK1G2 | 0.27575902 |
| 102 | RPS6KA3 | 0.27328823 |
| 103 | PRKACB | 0.26581912 |
| 104 | GRK5 | 0.26376179 |
| 105 | NLK | 0.26276019 |
| 106 | MAP2K1 | 0.24448637 |
| 107 | PRKACA | 0.24321139 |
| 108 | SCYL2 | 0.23929350 |
| 109 | MST1R | 0.23618454 |
| 110 | PRKG1 | 0.23000238 |
| 111 | WNK4 | 0.22973157 |
| 112 | EEF2K | 0.22682501 |
| 113 | GRK7 | 0.22502514 |
| 114 | LRRK2 | 0.22340050 |
| 115 | SGK494 | 0.21971966 |
| 116 | SGK223 | 0.21971966 |
| 117 | MAP3K11 | 0.21742573 |
| 118 | FER | 0.21209017 |
| 119 | EGFR | 0.21133569 |
| 120 | ABL2 | 0.20293615 |
| 121 | MAP3K5 | 0.19939206 |
| 122 | CDK15 | 0.18196463 |
| 123 | MAP3K1 | 0.18178005 |
| 124 | INSRR | 0.18103521 |
| 125 | MOS | 0.17381610 |
| 126 | CDK11A | 0.17314202 |
| 127 | ERN1 | 0.16596380 |
| 128 | MAPK4 | 0.16223456 |
| 129 | PDPK1 | 0.13882926 |
| 130 | GSK3A | 0.13652861 |
| 131 | PRKD1 | 0.13574881 |
| 132 | ROCK1 | 0.13240922 |
| 133 | MAPK13 | 0.12917177 |
| 134 | RPS6KA1 | 0.12827031 |
| 135 | PAK3 | 0.12737786 |
| 136 | RPS6KA2 | 0.11260782 |
| 137 | STK11 | 0.10028163 |
| 138 | DYRK1A | 0.09470950 |
| 139 | CAMK1G | 0.09174560 |
| 140 | CAMK2D | 0.09165077 |
| 141 | PRKACG | 0.08880948 |
| 142 | PDK1 | 0.08739140 |
| 143 | MAPK7 | 0.08000991 |
| 144 | RAF1 | 0.07989136 |
| 145 | TNK2 | 0.06541584 |
| 146 | MAP3K2 | 0.06266188 |
| 147 | MINK1 | 0.05398200 |
| 148 | DDR2 | 0.05388717 |
| 149 | JAK2 | 0.05260736 |
| 150 | MAPK8 | 0.04332281 |
| 151 | SGK3 | 0.04252575 |
| 152 | MAPK10 | 0.03968875 |
| 153 | EPHB2 | 0.03041829 |
| 154 | PRKCH | 0.02767324 |
| 155 | PRKCG | 0.02552078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.81007204 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.70539278 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.65528224 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.22775465 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.12184942 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.78615887 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.63986998 |
| 8 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.45279150 |
| 9 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.36727547 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.35090020 |
| 11 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.29600370 |
| 12 | Circadian rhythm_Homo sapiens_hsa04710 | 2.25524898 |
| 13 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.05194591 |
| 14 | Insulin resistance_Homo sapiens_hsa04931 | 1.95439757 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90831410 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.79439992 |
| 17 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.78213447 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 1.77871465 |
| 19 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.77272516 |
| 20 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.68665378 |
| 21 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.60344902 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.52858425 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.50508956 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45705517 |
| 25 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.43682992 |
| 26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.38255102 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37512045 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.36843005 |
| 29 | Tight junction_Homo sapiens_hsa04530 | 1.29666690 |
| 30 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.28658170 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.26618125 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26394294 |
| 33 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.20853057 |
| 34 | Melanoma_Homo sapiens_hsa05218 | 1.20239321 |
| 35 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19179996 |
| 36 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.18341451 |
| 37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.17779601 |
| 38 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.17118058 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.16707389 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10944353 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.10919213 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.08932368 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.06590437 |
| 44 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.05498697 |
| 45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05026207 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00810480 |
| 47 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.00004933 |
| 48 | Renin secretion_Homo sapiens_hsa04924 | 0.96150595 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.95796073 |
| 50 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.94556686 |
| 51 | Colorectal cancer_Homo sapiens_hsa05210 | 0.93787238 |
| 52 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.92405526 |
| 53 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.91709207 |
| 54 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.90088994 |
| 55 | Olfactory transduction_Homo sapiens_hsa04740 | 0.89832806 |
| 56 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.89250865 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.88705441 |
| 58 | Focal adhesion_Homo sapiens_hsa04510 | 0.88655877 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85816775 |
| 60 | Insulin secretion_Homo sapiens_hsa04911 | 0.84964310 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84036873 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82618328 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78994859 |
| 64 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77571762 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77477940 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.77475695 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77216317 |
| 68 | Axon guidance_Homo sapiens_hsa04360 | 0.74987754 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74626758 |
| 70 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.73055368 |
| 71 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.72134153 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.70731747 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70717207 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70601517 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67672228 |
| 76 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67348298 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66354180 |
| 78 | Circadian entrainment_Homo sapiens_hsa04713 | 0.65969087 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.63084936 |
| 80 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60143088 |
| 81 | Long-term depression_Homo sapiens_hsa04730 | 0.59400294 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57650447 |
| 83 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.56901076 |
| 84 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56581535 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56159522 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55551891 |
| 87 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.54168714 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53583874 |
| 89 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52420850 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51901615 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.51632051 |
| 92 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49162186 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45981652 |
| 94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45669667 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45259251 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45253698 |
| 97 | Long-term potentiation_Homo sapiens_hsa04720 | 0.44936490 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44526308 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43028559 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42829477 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41749023 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.41347293 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41277162 |
| 104 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40727519 |
| 105 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40458056 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | 0.39876729 |
| 107 | GABAergic synapse_Homo sapiens_hsa04727 | 0.39690287 |
| 108 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.39647938 |
| 109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38485366 |
| 110 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38207939 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37068026 |
| 112 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.37032635 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35539426 |
| 114 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34908795 |
| 115 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.34880066 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34355558 |
| 117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34048260 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.33873395 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33483033 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.33435657 |
| 121 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32138210 |
| 122 | Salivary secretion_Homo sapiens_hsa04970 | 0.32078438 |
| 123 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31296691 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30333397 |
| 125 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29159107 |
| 126 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.29125624 |
| 127 | Gap junction_Homo sapiens_hsa04540 | 0.28511929 |
| 128 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.28137606 |
| 129 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.27724544 |
| 130 | Phototransduction_Homo sapiens_hsa04744 | 0.27658393 |
| 131 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26678324 |
| 132 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26298006 |
| 133 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25380500 |
| 134 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.25317973 |
| 135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23524037 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.23346937 |
| 137 | ABC transporters_Homo sapiens_hsa02010 | 0.22544826 |
| 138 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22506799 |
| 139 | Melanogenesis_Homo sapiens_hsa04916 | 0.21092850 |

